APLNR and diabetes mellitus: Numerous studies have shown that APLN/APLNR polymorphisms are associated with the risk of several diseases such as hypertension, CAD, and diabetes mellitus (Nowzari et al., 2018; Wu et al., 2018; Zhang et al., 2019).